- ADAP Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
-
8-K Filing Data
Adaptimmune Therapeutics (ADAP) 8-K2 Aug 24Approved for advanced MAGE-A4+synovial sarcoma in adults with certain HLA types who have received prior chemotherapyFinancial data
Company Profile